Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
- Regenerative medicine
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 213335
IPSCIO Record ID: 359108
Cannabidiol is a non-psychoactive molecule with broad therapeutic potential in the treatment of chronic inflammatory disease including heart failure.
Field of use to treat cardiovascular disease, cardiopulmonary disease, and cardiac arrhythmias.
IPSCIO Record ID: 230517
The IP includes products and technologies like MyoCell for the treatment of heart damage. These are autologous muscle-derived cellular therapies designed to populate regions of scar tissue within a patientâ€™s heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients.
MyoCell is an innovative clinical therapy designed to populate regions of scar tissue within a patientâ€™s heart with autologous muscle cells, or cells from a patientâ€™s body, for the purpose of improving cardiac function in chronic heart failure patients.